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Abstract
In the fission yeast, Schizosaccharomyces pombe, stress upon the cell division
machinery leads to the activation of a cytokinesis checkpoint. This checkpoint results in
a delay in cell cycle progression and the prolonged maintenance of a cytokinesis
competent cellular state. In this state the cell is able to continuously reform/repair the
actomyosin ring until cell division is achieved. To uncover genes that play a role in
enforcing this checkpoint, the actin depolymerizing drug Latrunculin A (LatA) was
used to perturb the cytokinetic machinery in a set of 3400 viable haploid S. pombe gene
deletion mutants. Thirty-eight gene deletion mutants hypersensitive to LatA were
identified in this screen. Among this set of genes, the transcription factor adhesion
defective protein 2 (adn2) showed one of the strongest phenotypes in response to LatA
and was thus characterized further.

Interestingly, live-cell imaging experiments

showed that adn2 gene deletion mutants, while initially able to assemble the
actomyosin ring, were unable to properly constrict the ring in the presence of LatA
leading to cell division failure.

Furthermore, over-expression experiments

demonstrated that abnormally high levels of Adn2p result in morphological/cytokinetic
phenotypes suggesting a possible dominant-negative effect.

Keywords: Fission yeast, Cell division, Cytokinesis, Cell cycle checkpoint,
Latrunculin A, Actin, Actomyosin ring
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Chapter 1

1

Introduction
1.1 A checkpoint system is required for the faithful
execution of cytokinesis in Schizosacharomyces
pombe
Cytokinesis is the final step of the cell cycle in which a cell divides to give rise

to two daughter cells, each containing a full genomic complement and an equal
distribution of organelles (Fededa & Gerlich, 2012). The faithful and reliable execution
of cytokinesis is carefully monitored and depends on the coordination of numerous
spatial and temporal events (Balasubramanian et al., 2004). For example, cytokinesis
must be spatially regulated to occur only between segregated chromosomes. It must
also be temporally regulated to occur after mitosis to ensure a full DNA complement is
segregated to each daughter cell. Failure of proper spatial and temporal regulation of
cytokinesis can compromise genomic integrity and negatively impact cell viability
(Prekirs & Gould, 2008).
The association between cytokinesis failure and cell viability was first described
in Theodore Boveri’s 1914 work ‘Concerning the Origin of Malignant Tumours’. In his
work, Boveri links cytokinesis failure and the resulting genomic instability with tumour
development. Boveri hypothesized that a consequence of cytokinesis failure was the
formation of tetraploid cells, which in addition to containing extra chromosomes, also
contain extra centrosomes. The presence of multiple centrosomes renders the transient
tetraploid cells susceptible to undergoing a chaotic multipolar mitosis (as opposed to a
bipolar mitosis) in which chromosomes are mis-segregated as a result of being pulled to
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multiple poles. The cells resulting from this chaotic multipolar mitosis are genetically
unstable aneuploids. Due to additional or missing chromosomes these cells are more
likely to become malignant (Harris et al., 2008). The direct link between cytokinesis
failure and genomic integrity emphasizes the importance of understanding the
mechanisms that ensure the faithful and reliable execution of cytokinesis.
Today it is clear that aneuploidy is a common feature of human cancers.
Furthermore, numerous experiments support Boveri’s hypothesis that cytokinetic
failure leads to tumour formation (Olaharski et al., 2006; Ganem et al., 2007; Holland
& Cleveland, 2009). In one experiment, diploid mouse ovarian surface epithelial cells
that had failed in cytokinesis were observed to experience an intermediate tetraploid
stage before evolving to aneuploidy. Injection of the aneuploid cells into mice resulted
in tumour formation at the site of injection (Lv et al., 2012).
Additional experiments have identified tumour suppressor proteins such as
BRCA2 and p53 that are required for the faithful completion of cytokinesis (Daniels et
al., 2004; Fujiwara et al., 2005). While research has established a direct relationship
between cytokinesis failure and tumour formation, our understanding of the
mechanisms in place for the faithful and reliable execution of cytokinesis is lacking
(Karagiannis, 2012). An understanding of the mechanisms required for the successful
completion of cytokinesis is important as it can deepen our understanding of basic
eukaryotic cell biology and provide insight into mammalian tumour development.
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1.2

Cytokinesis in eukaryotes

Much of our understanding of cytokinesis comes from experiments using model
organisms.

Organisms amenable to genetic manipulation such as Saccharomyces

cerevisiae, Drosophila melanogaster, and Schizosaccharomyces pombe have served as
powerful tools in elucidating the components of cytokinesis.

In animal cells,

cytokinesis normally proceeds through a series of tightly coordinated and regulated
steps beginning with specification of the cleavage plane, formation and constriction of
the actomyosin ring, and finishing with the physical separation of the two cells (Fededa
& Gerlich, 2012). The major events of cytokinesis are conserved among organisms,
and this is particularly evident when comparing animal cell and fission yeast
cytokinesis (Pollard & Wu, 2010) (Figure 1-1).
In animal cells the site of cell division and future contractile ring assembly is
determined during anaphase by the mitotic spindle after sister chromatid separation
(Eggert et al., 2006; Barr & Gruenebrg, 2007). During early anaphase, kinetochore
microtubules attach to the kinetochore of a chromosome, driving the segregation of
sister chromatids to opposite spindle poles. Once chromosomes have been separated to
opposite halves of the cell, polar microtubules emanating from opposite spindle poles
compact into overlapping, antiparallel bundles to form the central spindle. The central
spindle serves as a regulating center for cytokinesis by recruiting proteins necessary for
cleavage furrow positioning and future abscission (Glotzer, 2001; Guertin et al., 2002).
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Figure 1-1. Cytokinesis in the fission yeast, S. pombe, and in animal cells. Both
animal cells and S. pombe divide via medial fission using an actin and myosin based
contractile ring. Specification of the division plane occurs during G2 in S. pombe and
during anaphase in animal cells. Reproduced from Pollard & Wu (2010) under the fair
use provision of the Canadian Copyright Modernization Act (2012).
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The actomyosin ring is positioned in the medial region of the cell and constricts
to create an indentation on the cell surface known as the cleavage furrow. As the
actomyosin ring constricts the furrow ingresses and drags the plasma membrane
inward, partitioning one cell into two daughter cells. Ring constriction also compresses
the microtubules of the spindle midzone into a transient, narrow intracellular bridge
known as the spindle midbody that connects the two cells for a short period. In the
final step of cytokinesis, the midbody recruits proteins required for abscission and
vesicles deliver newly synthesized membrane material to the midbody (Guertin et al.,
2002; Glotzer, 2005).
Like animal cells, cytokinesis in S. pombe relies on the formation and
constriction of an actomyosin ring in the medial region of the cell to complete
cytokinesis (Simanis, 1995). Unlike animal cells, S. pombe is surrounded by a cell
wall, which requires the deposition of a polysaccharide septum concomitant with ring
constriction.

The eventual degradation of the septum causes cell scission

(Balasubramanian et al., 2004). Both animal cells and S. pombe have mechanisms in
place to ensure that ring constriction does not occur prior to chromosome segregation,
as mis-segregation of chromosomes can disrupt genomic integrity (Glotzer & Simanis,
1997; Glotzer 2001; Guertin et al., 2002). Currently, we do not have a thorough
understanding of the mechanisms that ensure the faithful and reliable execution of
cytokinesis and therefore require further research to deepen our understanding
(Karagiannis, 2012).
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1.3 Schizosaccharomyces pombe as a model organism
for studying cytokinesis
The elucidation of cell cycle control mechanisms in fission yeast by Nobel
laureate Paul Nurse made S. pombe a commonly used model organism for the study of
diverse biological processes, most notably the cell cycle (Nurse et al., 1976, Nurse &
Thuriaux., 1980, Lee & Nurse, 1987). In particular S. pombe has been used to research
eukaryotic cytokinesis since the basic mechanisms of cytokinesis and general order of
events are shared between S. pombe and animal cells (Wolfe & Gould, 2005). Both use
a contractile actomyosin ring to divide, share most genes used in cytokinesis and both
have regulatory mechanisms in place to ensure cytokinesis occurs after mitosis
(Balasubramanian et al., 2004).

The conservation of these basic mechanisms in

cytokinesis should provide insights into cytokinesis in other organisms (Pollard & Wu,
2010).
In addition to the shared similarities with human cells, S. pombe is also
genetically tractable (Balasubramanian et al., 2004). S. pombe has a simple haploid
genome on three chromosomes that have been fully sequenced and annotated (Wood et
al., 2002). Due to the relatively simple genome, deletion strains are available for 98%
of the ~4900 total genes in S. pombe. Furthermore, many cytokinesis proteins have
been tagged with fluorescent markers. Finally, a large number of cytokinesis defective
mutants have been identified in S. pombe (Karagiannis, 2012).
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1.4

Cytokinetic mechanisms in S. pombe

The execution of cytokinesis in S. pombe, just as in more complex eukaryotes,
relies on the formation and constriction of an actomyosin ring in the medial region of
the cell. In S. pombe the position of the interphase nucleus determines the location of
the future division site (Guertin et al., 2002). The position of the actomyosin ring is
coupled to nuclear position via the nuclear export of anillin-like nuclear protein, Mid1p,
in a Plo1p-dependent manner (Bahler & Pringle, 1998; Daga & Chang, 2005). Mid1p
localizes to the cortex overlying the nucleus, marking the future division site (Figure
1-2). Mid1p also serves as a spatial cue for the recruitment of ring components to the
medial region during interphase (Bahler & Pringle, 1998; Daga & Chang, 2005; Huang
et al., 2007). These protein clusters in the medial region of the cell are known as
interphase nodes and represent the first step in actomyosin ring assembly (Guertin et
al., 2002). Additional proteins including Wee1p, Cdr1p and Cdr2p also localize to
interphase nodes at the onset of mitosis (Wu & Pollard, 2005; Bathe & Chang, 2010;
Almonacid & Paoletti, 2010).
Interphase nodes are restricted to the middle of the cell by the kinase Pom1p,
which forms a polar gradient at both ends of the cell (Celton-Morizur et al., 2006;
Moseley et al., 2009). As the cell grows lengthwise during G2, the levels of Pom1p in
the middle of the cell decrease, triggering mitosis by releasing inhibition of Cdr1p and
Cdr2p kinases.

Cdr1p and Cdr2p negatively regulate the kinase Wee1p through

phosphorylation. When phosphorylated, Wee1p is no longer able to inhibit the cyclin
dependent kinase, Cdc2p, which controls cell cycle progression. Release of Cdc2p
inhibition by Wee1p triggers the transition from G2 into mitosis and occurs
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coincidently with chromosome segregation (Morgan, 1997). This system ensures that
ring assembly is tightly coordinated with mitotic entry and does not initiate before
chromosomes have been segregated (Guertin et al., 2002).

9

Figure 1-2. Cytokinesis in Schizosaccharomyces pombe. Mid1p localizes to the cell
cortex overlying the nucleus where it recruits ring components to the median in clusters
known as interphase nodes (green circles). The interphase nodes mark the site for future
actomyosin ring assembly. The polymerization of actin filaments by Cdc12p and
maturation of interphase nodes into cytokinesis nodes is followed by node compaction
into a tightly bundled ring (shown in red). SIN signaling initiates ring constriction and
septum assembly. Actin patches are shown as pink circles. Microtubules are shown as
green filaments. Reproduced from Pollard and Wu (2010) under the fair use provision
of the Canadian Copyright Modernization Act (2012).
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Once the cell has entered mitosis, interphase nodes mature into cytokinesis
nodes through the addition of myosin II and the ring proteins, Rng2p (ring assembly
protein), Cdc15p, and Cdc12p (Moseley et al., 2009). Actin is assembled into the ring
by the formin Cdc12p, which interacts with actin monomers, aiding their
polymerization into filaments. Tropomyosin and fimbrin then condense the actin into a
compact ring (Kovar et al., 2003; Wu & Pollard, 2005; Wu et al., 2006).
Once the ring is formed, the timing of its constriction and the initiation of
cytokinesis are coordinated to occur with the completion of the preceding mitosis
(Wolfe & Gould, 2005).

In S. pombe, ring constriction and septum formation is

controlled by a kinase signaling cascade known as the Septation Initiation Network
(SIN) (Simanis, 1995; Krapp & Simanis, 2008). Components of the SIN assemble at
the spindle pole body, the S. pombe counterpart of the mammalian centrosome (Hou et
al., 2000). The SIN signaling cascade consists of three kinases, Cdc7p, Sid1p, and
Sid2p, along with the small GTPase, Spg1p. Sid4p and Cdc11p are scaffold proteins
that remain at the SPB during all cell cycle stages and anchor the SIN kinases to the
SPB during mitosis (Krapp & Simanis, 2008). The small GTPase Spg1p controls SIN
signal transduction. During interphase Spg1p remains at the SPB, bound to Byr4pCdc16p in its inactive GDP bound form, inhibiting SIN signaling and thereby
preventing septation from occurring during interphase. During metaphase, decreasing
levels of Cdc16p allow Spg1p to dissociate from the Byr4p-Cdc16p complex. In its
now active GTP-bound form, Spg1p recruits Cdc7p to the SPB. This leads to the
recruitment of Sid4p-Cdc11p to the SPB. The recruitment of Sid4p-Cdc11p to the SPB
causes Sid2p-Mob1p to re-localize from the SPB to the site of cell division to initiate
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ring constriction and division septum formation. Degradation of the septum and release
of the two daughter cells completes cytokinesis (Schmidt et al., 1997; Tomlin et al.,
2002; Mishra et al., 2005).

1.5 Comparison of cytokinesis in Schizosaccharomyces
pombe and animal cells
The major events of cytokinesis include cleavage plane specification,
rearrangement of the cytoskeleton/microtubules, contractile ring assembly, constriction,
and abscission. In general, the major events of cytokinesis are conserved in S. pombe
and animal cells, although structural and regulatory differences between the two require
the utilization of different strategies to complete cytokinesis (Balasubramanian et al.,
2004).
One of the earliest steps in cytokinesis is specification of the division plane –
the site of future actomyosin ring formation and cell division (Almonacid & Paoletti,
2010). To ensure equal partitioning of genomic and cytoplasmic content, most
eukaryotes position the division plane perpendicular to the axis of chromosome
segregation in the medial region of the cell (Eggert et al., 2006).

However, the

mechanism and timing of division plane specification varies between fission yeast and
animal cells. In animal cells the cleavage plane is determined during anaphase and
reflects the position of the mitotic spindle. In fission yeast the future site of cell
division is determined in G2 by the position of the interphase nucleus
(Balasubramanian et al., 2004; Gould, 2005).
Both mammalian and fission yeast divide by the formation and constriction of
an actomyosin ring. In both organisms, actin and myosin are used to contract the ring
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(May, 1997; Kitayama, 1997).

The basic composition of the ring in animal and

S. pombe cells is very similar, and many conserved families of proteins required for
ring assembly are common to both organisms such as actin, myosin II, and formins
(Bezanilla et al., 1997; Wu, 2002; Pollard & Wu, 2010).

While many of the

components that make up the actomyosin ring are conserved, the timing of ring
assembly is different. In S. pombe components required for ring assembly localize to
the medial region in G2, although ring assembly occurs once the cell enters mitosis
(Balaubramanian et al., 2004). In animal cells actomyosin ring assembly occurs closer
to the end of mitosis, during anaphase (Rappoport, 1996, Glotzer, 2001).
At the end of cytokinesis, the cell must ensure that daughter cells receive an
equal amount of cytoplasmic material and proteins, which requires an increase in cell
volume. In animal cells membrane material is added or redistributed during cytokinesis
(Glotzer, 2005). In S. pombe the presence of a cell wall requires the deposition of a
polysaccharide septum as the ring constricts (Wolfe & Gould, 2005). The majority of
the surface area required for both daughter cells is generated during interphase when
the cell is undergoing polarized growth. During cytokinesis only the relatively narrow
membrane and cell wall material that divides the cell during abscission must be added
(Balasubramanian et al., 2004).

1.6

The cytokinesis checkpoint system

Progression through the cell cycle in S. pombe is monitored by cell cycle
checkpoints. As the cell progresses through the phases of the cell cycle, checkpoints
ensure completion of one phase prior to the initiation of a subsequent phase (Hartwell
& Weinert, 1998). Checkpoint failure results in abnormal progression through the cell
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cycle and ultimately renders cells inviable.

For example, the SIN ensures that

cytokinesis begins only once the preceding mitosis is complete and chromosomes have
been equally segregated. Recently there has been evidence of a cytokinesis monitoring
checkpoint in S. pombe which ensures cytokinesis completion prior to the initiation of
the subsequent mitosis (Krapp & Simanis, 2008; Karagiannis, 2012).
Evidence of a cytokinesis checkpoint can be observed when the cytokinetic
machinery is mildly stressed. Under these conditions cells are held in a prolonged
cytokinesis competent state during interphase and will delay entry into the next round
of mitosis to give the cell time to stabilize/re-establish the actomyosin ring (Liu et al.,
2000; Le Goff et al., 1999; Trautmann et al., 2001; Mishra et al., 2004; 2005).
Evidence of a cytokinesis checkpoint comes from the characterization of cytokinesis
mutants – that when exposed to mild perturbation to their cytokinetic machinery – are
incapable of arresting the cell cycle or maintaining a prolonged cytokinesis competent
state. As a result, these cells do not complete cytokinesis (Le Goff et al., 1999; Liu et
al., 2000; Trautmann et al., 2001). The cytokinesis checkpoint involves the SIN, the
Clp1p phosphatase, and the 14-3-3 protein Rad24p (Liu et al., 2000; Karagiannis et al.,
2005; Mishra et al., 2005; Karagiannis, 2012).

1.7 Using latrunculin A to screen for genes involved in
the cytokinesis checkpoint
Genes with a role in the cytokinesis checkpoint can be identified by screening
gene deletion mutants with the actin depolymerizing drug Latrunculin A (LatA). LatA
is a toxin produced by the Red Sea Sponge. It sequesters actin monomers, preventing
their polymerization into a filamentous structure (Ayscough et al., 1997). In this way
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LatA treatment inhibits assembly of the actomyosin ring. LatA has commonly been
used in experiments at high concentrations (10-50 μM) to completely disrupt the
actomyosin ring.

However, LatA can also be used in low doses (0.2 – 0.5 μM) to

mildly stress the cytokinetic machinery (Ayscough, 1997).

This activates the

cytokinesis checkpoint system to prolong cytokinesis as the cell attempts to
reform/repair the actomyosin ring (Ayscough et al., 1997; Mishra et al., 2004; 2005).
Upon treatment with low dose LatA, mutants bearing deletions in genes critical
to the cytokinesis checkpoint are unable to arrest the cell cycle or maintain a
cytokinesis competent state in order for the cell to re-establish the actomyosin ring.
The inability to delay entry into the next round of mitosis causes continuous rounds of
nuclear division in the absence of cytoplasmic division and results in elongated,
multinucleated cells with a fragmented septum (Wolfe & Gould, 2005) (Figure 1-3).
Wild-type cells, however, are able to delay entry into the subsequent mitosis upon mild
perturbation of the cytokinetic machinery. A functional cytokinesis checkpoint ensures
that cytokinesis is complete prior to entry into the subsequent round of mitosis,
resulting in successful cell division (Karagiannis et al., 2005; Mishra et al., 2005).
Analysis of these mutants can therefore allow us to better understand the molecular
mechanisms underlying the cytokinesis checkpoint.
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Figure 1-3 Cellular phenotypes upon LatA treatment. Both wild-type cells and
cytokinesis checkpoint mutants (e.g. clp1Δ) are able to complete cytokinesis under
normal growth conditions (left panel). Upon treatment with low doses of LatA, wildtype cells can delay entry into mitosis through activation of the cytokinesis checkpoint,
which maintains a cytokinesis competent state (middle panel). Cytokinesis checkpoint
mutants are unable to activate this checkpoint upon mild perturbation of the actomyosin
ring and cannot delay mitosis until cytokinesis is completed. As a result, cells are
elongated and multinucleated (right panel). The actomyosin ring is shown as a red
circle. Actin patches are shown as red dots. The nucleus is shown as a black circle.
The spindle pole body (active) is shown as a blue dot. Reproduced from Karagiannis et
al. (2004) under the fair use provision of the Canadian Copyright Modernization Act
(2012).
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1.8

Rationale

While a variety of mutants hypersensitive to LatA have been isolated and
characterized (Karagiannis et al. 2005; Karagiannis and Balasubramanian, 2007;
Saberianfar et al., 2011; Grewal et al., 2012; Rentas et al., 2012), a global assessment of
the regulatory modules needed to respond to LatA-mediated perturbation is lacking.
The Bioneer deletion mutant library (Kim et al., 2010) was thus used to identify genes
that play a role in defending against LatA-induced stress on a genome-wide scale. To
perform the genome-wide screen, strains were treated with 0.4 μM LatA, as this
concentration is close to the dissociation constant for LatA, and only mildly disrupts the
actin cytoskeleton.

In this way the regulatory modules needed to mitigate the

detrimental effects of abnormal cytoskeletal perturbations could be identified.

In

addition to the genome-wide screen, the detailed characterization of one of the
identified genes, adn2, is presented as part of this thesis.
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Chapter 2

2

Materials and Methods
2.1

Strains, media, and growth conditions

Schizosaccharomyces pombe strains used in this study were obtained from the
commercial supplier (Bioneer Corporation) or from the Karagiannis laboratory
collection. Unless stated otherwise, strains were cultured to mid-log phase (OD600
between 0.2-0.6) in yeast extract medium (YES) with supplements (adenine, histidine,
leucine, and uracil) at 30°C with shaking at 150 rpm. Strains carrying auxotrophic
markers were grown in Edinburgh minimal media (EMM) with supplements (uracil,
adenine, histidine and/or leucine).

To induce mating, strains were cultured in

sporulation medium with supplements (SPAS) (Forsburg and Rhind, 2006). NEB 5alpha competent Escherichia coli strains were used for molecular cloning experiments.
Cells were made competent for transformation by placing them on ice for 30 minutes,
followed by heat shock at 42°C for 30 seconds. After transformation, cells were grown
on solid Lysogeny broth (LB) agar media with 100 µg/ml ampicillin, at 37°C.

2.2

Primary screen

An individual trial of the screen was performed using version 4 of the Bioneer
genome-wide deletion mutant library.

The library consists of 3400 haploid gene

deletion mutants comprising ~ 95.3% of non-essential S. pombe genes. Each strain
carries a defined gene deletion constructed with the kanMX4 cassette (Kim et al. 2010).
To assay LatA sensitivity, the gene deletion mutants were grown in 96-well microtiter
plates in liquid YES medium (Forsburg and Rhind, 2006) at 30°C. Five microliter
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aliquots were then spotted onto YES-agar medium containing 0.4 μM Latrunculin A
(Focus Biomolecules) or YES-agar media containing an equivalent volume of DMSO
(solvent control). The growth of the strains on LatA plates (relative to DMSO controls)
was assayed visually after 3 days at 30°C. Results of the screen were collated with two
other trials (performed by collaborator, F. Asadi). Hits were categorized into three
groups: a “high-confidence” group consisting of gene deletion mutants that were scored
as sensitive in each of the three trials, a “medium-confidence” group consisting of gene
deletion mutants that were scored as sensitive in two of the three trials, and a “lowconfidence” group consisting of gene deletion mutants that were scored as sensitive in
only one of the three trials.

2.3

Spot assays

The respective gene deletion mutants of the high-confidence group were grown
overnight at 30°C in liquid YES medium to an OD600 of 0.5. Five microliters of
undiluted culture, as well as four ten-fold serial dilutions (made in liquid YES), were
then spotted onto YES-agar plates containing DMSO (solvent control) or 0.1 μM, 0.2
μM, or 0.3 μM LatA. Growth was assayed visually after the plates had been incubated
for four days at 30°C.

2.4

Disk diffusion assays

The respective gene deletion mutants of the high-confidence group were grown
overnight at 30°C in liquid YES medium to an OD600 of 0.5. Cells at a concentration of
105 cells/mL were then mixed with molten YES-agar (~40°C) and poured into Petri
dishes. Five microliters of DMSO (solvent control), or 2.2 μM, 4.4 μM, or 6.6 μM
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LatA, were then spotted onto sterile filter paper disks (Whatmann No. 1) which were
subsequently placed onto the surface of the respective YES-agar plates. Photographs
were taken using a Fluor Chem SP imager after the plates had been incubated for four
days at 30°C. The area of the zone of inhibition for each disk was measured using
ImageJ software (https://imagej.nih.gov/ij/). The area of the zone of inhibition for each
disk (measured in pixels) was then plotted against LatA concentration. The slope of the
linear regression line was calculated using Microsoft Excel.

2.5

Minimum inhibitory concentration assays

The respective gene deletion mutants of the high-confidence group were grown
overnight at 30°C in liquid YES media to an OD600 of 0.5. Approximately 105 cells of
each mutant strain was then seeded into the wells of a 96-well microtiter plate
containing 100 μL of YES medium with 0 μM, 0.025 μM, 0.05 μM, 0.075 μM, 0.1 μM
or 0.2 μM LatA. The plates were incubated for 4 days at 30°C. The minimum
inhibitory concentration was determined by visually inspecting the plates to ascertain
the lowest concentration of LatA that prevented visible growth.

2.6

Fluorescence microscopy

The respective gene deletion mutants of the high-confidence group were grown
overnight at 30°C in liquid YES medium to an OD600between 0.2 and 0.6. The cultures
were then treated with DMSO or 0.3 μM LatA for five hours. Cells were fixed with two
volumes of ice-cold ethanol and then spun at 5000 rpm for two minutes and resuspended in 1 mL of PBS (pH 7.4) containing 1% Triton X-100. Cells were washed
three times in PBS before being re-suspended in 100 µL of PBS containing 15%
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glycerol. To observe nuclei and cell wall/septa material, cells were mixed with 0.02
mg/mL 4’6-diamidino-2-phenylindole (DAPI) and 1 mg/mL aniline blue. Fluorescence
images (DAPI filter set) were obtained with a Zeiss Axioskop 2 microscope attached to
a Scion CFW Monochrome CCD Firewire Camera (Scion Corporation, Frederick
Maryland). The microscope system was driven by ImageJ 1.41 software (National
Institutes of Health).

2.7

Molecular cloning

Molecular cloning was performed using New England Biolabs 5-alpha
competent E. coli cells according to the supplier’s protocol. Briefly, E. coli cells were
thawed on ice for 10 minutes and 1-5 μl of plasmid DNA was added. Cells were
incubated for 30 min on ice and were then heat shocked at 42°C for 30 seconds. Cells
were then placed on ice for 5 minutes. Cells were serially diluted using LB and plated
on LB + ampicillin (100 µg/ml) at 30°C for 24 hours. Plasmids were isolated from E.
coli using the Geneaid High Speed Plasmid Mini-Kit according to the supplier’s
protocol.

2.7.1

Creation of the pJK210-adn2-GFP construct
The pJK210-adn2-GFP construct was created using PCR-based cloning. The

carboxy terminus of the adn2 gene was amplified by PCR from wild-type genomic
DNA

using

the

following

primers

GGGGGGAATTCTGACCTGATAGACCGCTTTCTCAG-3’;
GGGGGCCCGGGAGCAGCAGTCGAGTCTTCATT-3’).

(forward:

5’-

reverse:

5’-

The amplicon was then

cloned in frame and upstream of the GFP gene using the EcoRI and XmaI sites present
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in the pJK210-GFP plasmid. The plasmid was then transformed into wild-type strain,
JK484, using the lithium acetate method (Forsburg and Rhind, 2006). The transformed
cells were selected by growth on EMM solid media lacking uracil. The transformant
cells were further verified for locus specific homologous recombination by colony PCR
using the following primers (forward: 5’-CCTAAACCTGCTCAACAGCC-3’; reverse:
5’-TGGGACAACTCCAGTGAAAA-3’).

2.7.2

Creation of the pREP1-adn2, pREP41-adn2 and pREP81adn2 over-expression constructs
The full length adn2 gene was PCR amplified from wild-type genomic DNA

using primers flanked by XmaI and NdeI sites (forward: 5’-GGCGGCATATGGCTG
ATCCAGGTTTAAGGT-3’;

reverse:

5’-GGCGGCCCGGGTTAAGCAGCAGTC

GAGTCTTCATTA-3’). Both the pREP series of vectors and the PCR amplicon were
digested using XmaI and NdeI restriction enzymes by incubating for 1 hour at 37°C.
The plasmid and amplicon digests were run and purified from a 1% agarose gel. The
adn2 gene was then ligated to the digested pREP series of plasmids using the New
England Biolabs Quick Ligation kit according to the supplier’s protocol.

2.8

Live cell imaging

Rlc1-GFP expressed from the native rlc1 promoter was used as a marker to
monitor actomyosin ring constriction in live cells. Cells were cultured in liquid YES to
mid-log phase at 30ºC and then treated with 0.2 μM LatA or DMSO (solvent control).
Cells were then visualized under the GFP filter set by time-lapse fluorescence
microscopy using a LEICA DMI6000B inverted fluorescence microscope.
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2.9

adn2 over-expression analysis

The pREP1-adn2, pREP41-adn2, and pREP81-adn2 plasmids were transformed
into wild-type S. pombe cells using the lithium acetate method (Forsburg and Rhind,
2006) and Leu+ transformants isolated. Strains containing the respective constructs
were then cultured in EMM supplemented with thiamine (10 µM) and lacking leucine
to mid-log phase. 1 mL of each culture was then used to inoculate fresh liquid EMM
containing thiamine (+T) or lacking thiamine (-T). Cells were grown for a further 18
hours and treated with DMSO or 0.1 μM, 0.2μM or 0.3 μM of LatA. Cells were then
cultured for a further 5 hours before being fixed with ethanol and stained with
DAPI/aniline blue. Cells were imaged as described in Section 2.6.
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Chapter 3

3

Results
3.1

Primary screen

When challenged with low doses of LatA (0.2 - 0.5 μM), fission yeast mutants
defective in the cytokinesis checkpoint system exhibit a terminal phenotype
characterized by inviable multi-nucleate cells that have failed in cytokinesis.

In

contrast, wild-type cells remain viable under these same conditions and are able to
complete cytokinesis, albeit over a longer time-frame than normal (Mishra et al. 2004;
Mishra et al. 2005; Chen et al. 2005; Karagiannis et al. 2005; Karagiannis and
Balasubramanian, 2007; Saberianfar et al. 2011; Rentas et al., 2012). It was thus
reasoned that this characteristic LatA sensitive phenotype could be used as the basis of
a screen aimed at identifying novel genes with roles in promoting successful cell
division upon perturbation of the cytokinetic machinery. It was also reasoned that the
screen would prove useful in identifying genes with roles in adapting to LatA induced
cytoskeletal stress in general. Version 4 of the Bioneer gene deletion library (Kim et
al., 2010) was thus obtained and used to carry out a screen for deletion mutants
exhibiting hypersensitivity to LatA. A schematic providing a broad overview of the
screen described in this thesis is shown in Figure 3-1.
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Figure 3-1 Overview of the genetic screen described in this thesis. A total of 3400
strains derived from the Bioneer fission yeast gene deletion mutant library were
screened on YES-agar media containing DMSO (solvent control) or 0.4 μM LatA. A
total of 38 strains were scored as hits in all three trials (high-confidence group), 77
strains were scored as hits in two of three trials (medium-confidence group), and 173
strains were scored as hits in one of three trials (low-confidence group). The highconfidence hits were further validated and analyzed by spot assays, disk diffusion
assays, minimum inhibitory concentration (MIC) assays, and by fluorescence
microscopy.
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The entire library of 3400 strains was screened by plating the gene deletion
mutants on YES medium containing 0.4 μM LatA and incubating them for 3 days at
30°C (see Materials and Methods). Growth was compared to the same mutants plated
on YES medium containing DMSO (solvent control). To minimize false negatives, the
primary screen was performed in triplicate. Three strains were used as controls: lskΔ, a
known LatA sensitive mutant showing low to moderate sensitivity (Karagiannis et al.,
2005), pap1Δ, a mutant known to be hypersensitive to a wide variety of toxins (and
which we observed to be highly sensitive to LatA; J. Karagiannis and B. Chakraborty,
unpublished), and lastly, a wild-type strain. Representative plates from one trial of the
screen are shown in Figure 3-2A.
After completing the primary screen, we categorized the hits into three groups: a
“high-confidence” group of 38 strains, a “medium-confidence” group of 77 strains, and
a “low-confidence” group of 173 strains (Figure 3-2B; Appendix A). The “highconfidence” group comprised of gene deletion mutants that were scored as hits in each
of the three trials. The “medium-confidence” group comprised gene deletion mutants
that were scored as hits in two of the three trials. Finally, the “low-confidence” group
comprised gene deletion mutants that were scored as hits in only one of the three trials.
Of eight previously characterized LatA sensitive mutants present in version 4 of the
library, two were present in the low confidence group (lsk1Δ, hos2Δ), and six were
present in the medium-confidence group (clp1Δ, rad24Δ, lsg1Δ, sif2Δ, snt1Δ, set3Δ).
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Figure 3-2 Primary screen. (A) All 3400 gene deletion strains from the Bioneer
collection were spotted to YES-agar plates containing DMSO (solvent control) or 0.4
μM LatA and then incubated for 3 days at 30°C. Two representative plates from the
screen are shown. A wild-type strain, as well as two hyper-sensitive mutants, lsk1Δ,
and pap1Δ, were used as controls (green circles). Two “hits”, rpl2102 and mcl1Δ are
also highlighted (red circles). (B) Venn diagram analysis of the three trials of the
primary screen. Thirty-eight hits were common to all three trials and comprise the
high-confidence group (red). Seventy-seven hits were common to two of the trials and
comprise the medium-confidence group (green). One hundred and seventy-three hits
were common to one of the three trials and comprise the low-confidence group (blue).
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While the low-confidence group is likely high in false positives, I include the
data here for the sake of completeness. Moreover, the fact that both lsk1Δ and hos2Δ
were categorized as low-confidence hits suggests that the group contains at least some
true positives. In contrast, the high- and medium-confidence lists, while lower in false
positives, must by the same token suffer from higher false negative rates. Thus, by
including the complete primary data set in its entirety (high-, medium-, and lowconfidence lists), I strike the best balance with respect to mitigating the effects of false
negative and false positive categorizations and provide the broadest resource possible.

3.2

Secondary screening

Having completed the primary screen, I focused on the deletion mutants of the
high confidence group for the remainder of the study. Ten-fold serial dilutions of
logarithmically growing cultures of each of the high confidence hits were spotted onto
YES medium containing DMSO or 0.1 μM, 0.2 μM, or 0.3 μM LatA.

These

experiments verified that the mutants were indeed hyper-sensitive to LatA (Figure 33). The sensitivity of the mutants varied from mild (capable of moderate growth on 0.3
μM LatA relative to wild-type) to severe (incapable of growth even at 0.1 μM LatA).
To provide a more quantitative assessment of LatA sensitivity, a series of disk
diffusion assays were performed (see Materials and Methods). In these assays filter
paper disks soaked in DMSO (solvent control), or 2.2 μM, 4.4 μM, or 6.6 μM LatA,
were placed on YES agar plates impregnated with the respective gene deletion mutants.
The plates were then incubated at 30°C for four days. Representative plates (pap1Δ
and wild-type controls, as well as three gene deletion mutants displaying varying levels
of sensitivity) are shown in Figure 3-4A.
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Figure 3-3 Spot assays. Ten-fold serial dilution of cultures of the indicated genotypes
were spotted onto YES-agar plates containing DMSO (solvent control), or 0.1 μM, 0.2
μM, or 0.3 μM LatA. Photographs were taken after four days incubation at 30°C.
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For each strain, the area of the zone of inhibition around each disk was plotted
against LatA concentration. Linear regression was then used to create a line of best fit
through the data points. The slopes of the lines were then calculated. Using this
quantitative measure it was possible both to validate the high confidence hits, as well as
accurately rank the strains according to their sensitivity to LatA (Figure 3-4B, Table 31).
Lastly, the mutants’ sensitivity to LatA was gauged by determining the
minimum inhibitory concentration (MIC) for each of the high confidence hits. This
was accomplished using the method of Tebbets et al. (2012). Briefly, 10 5 cells of an
overnight culture of each mutant were seeded into the wells of a microtiter plate. Each
well contained 100 μL of YES media containing LatA at concentrations ranging from
0.025 to 0.2 μM. The plates were then incubated at 30°C for four days. The MIC was
defined as the lowest concentration of LatA that prevented visible growth. The MICs
varied from >0.2 μM for wild-type cells to 0.025 μM for the most sensitive mutants
(Table 3-2).
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Figure 3-4 Disk diffusion assays. (A) Filter paper disks soaked with 5 µL of DMSO
(solvent control) or 2.2 µM, 4.4 µM, or 6.6 µM LatA, were placed on YES-agar plates
impregnated with the indicated gene deletion mutants. Photographs were taken after
four days incubation at 30°C. The zones of growth inhibition surrounding each disk
were measured and analyzed as described in the Materials and Methods. (B) A plot of
the area of the zone of inhibition vs. LatA concentration for a representative group of
10 gene deletion strains exhibiting varying sensitivity to LatA. The linear regression
line through the points is plotted. The slope of this line was used as a quantitative
measure to rank the LatA sensitivity of each strain.
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Table 3-1 Ranking of the LatA sensitivity of each gene deletion mutant based on linear
regression analysis of data plotting the area of the zone of inhibition (pixels) vs. LatA
concentration (µM).

Gene Deletion

kin1Δ
cch1Δ
efr3Δ
adn2Δ
mvp17Δ
pex14Δ
pka1Δ
mni1Δ
acp2Δ

SPCC794.03
SPCC70.06
SPAC9.02c

erg5Δ
tra1Δ
snd1Δ

SPAC3C7.07c
upf1 Δ
SPCC297.05
pap1Δ

pabpΔ
tup12Δ

SPCC4F11.03c

ngg1Δ
git5Δ
ain1Δ
exo2Δ
cat1Δ
git3Δ
ppk4Δ

SPBC725.10
SPCC1020.07

git11Δ
ppk33Δ

imp2Δ
apm3Δ
SPAC3H8.08c

end4Δ
but2Δ
cgs2Δ

Wild type

Rank
(Most Sensitive to
Least Sensitive)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

Slope of the
Linear Regression
Line (pixels/µM)
26505
22989
19765
19447
19283
17437
17303
17085
16543
16403
16360
15836
15748
15388
15216
14287
13785
12995
12108
10286
9763
9749
9289
8890
8717
8480
8312
8062
7802
7485
7064
6670
6669
6424
5886
5555
4862
4711
4080
1852
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Table 3-2 Minimum inhibitory concentration of LatA for the indicated gene deletion
mutants.

Gene Deletion
Mutant
ain1Δ
ppk4Δ
exo2Δ
erg5Δ
SPAC3H8.08c
mvp17Δ

pabpΔ
tup12Δ
acp2Δ
end4Δ
cch1Δ
cat1Δ
SPAC9.02c
pka1Δ
imp2Δ
adn2Δ
mni1Δ
git11Δ
ngg1Δ
but2Δ
kin1Δ
tra1Δ

SPCC1020.07
git3Δ
SPCC4F11.03c

snd1Δ

SPCC70.06

efr3Δ
upf1Δ

SPAC3C7.07c

pex14Δ
git5Δ
apm3Δ
SPBC725.10
ppk33Δ
cgs2Δ
SPCC297.05
SPCC794.03
pap1Δ
Wild type

Minimum Inhibitory
Concentration (µM)
0.1-0.2
.2
0.075
0.025-0.075
0.2
.05
0.1-0.2
0.025
0.1-0.2
0.2
>0.2
0.1-0.2
0.075-0.1
0.2
0.025
0.025
0.05
0.2
0.2
0.2
0.025
0.05
0.2
0.1-0.2
0.1
0.075-0.1
0.075
0.05-0.075
0.075-0.1
0.075-0.1
0.05-0.075
0.2
>0.2
0.1-0.2
0.2
0.075
>0.2
0.05
0.05-0.075
>0.2
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3.3

Screening for cytokinesis mutants

Having validated the high-confidence hits, it was important next to characterize
the nature of each mutant’s sensitivity to LatA. To screen for any obvious cytokinetic
phenotypes, the respective mutants were treated with 0.3 μM LatA for 5 hours. The cell
nuclei as well as cell wall/septal material were then visualized by fixing the cells and
staining with a mixture of DAPI and aniline blue. The cells were then classified into
one of four categories: 1) uninucleate cells, 2) bi-nucleate cells with complete septa, 3)
bi-nucleate cells with fragmented/incomplete septa, and 4) tetra-nucleate cells with
fragmented/incomplete septa.

We then calculated the ratio of binucleate or

tetranucleate cells with fragmented/incomplete septa, to uninucleate cells or binucleate
cells with complete septa.
While the wild-type control strain accumulated a majority of cells that were
uninucleate, or binucleate with complete septa, the 38 mutants of the high confidence
group accumulated much higher proportions of cells with fragmented/incomplete septa
(indicating failed constriction of the actomyosin ring) (Figure 3-5, Table 3-3). In fact,
15 of the 38 mutants (39%) exhibited a majority of cells with fragmented septa.
Importantly, although compromised in their ability to complete cytokinesis in the
presence of LatA, the high-confidence mutants were nevertheless fully capable of
successful cell division in the presence of DMSO. The mutants of the high confidence
group are thus defective in some aspect of their response to LatA-induced cytoskeletal
perturbation and are thereby more prone to cell division failure. The mechanism(s)
underlying the observed cytokinetic defects of the high confidence mutants are
unknown and will be the subject of future studies.

34

Figure 3-5 The gene deletion mutants of the high-confidence list are prone to
cytokinesis failure in the presence of LatA. Cells of the indicated genotype were
grown to mid-log phase and then treated with DMSO (solvent control) or 0.3 μM LatA
for 5 hours. Cells were fixed and stained with DAPI/aniline blue to visualize nuclei
and cell/wall septal material, respectively. Four strains from the high-confidence list
are shown as representative examples.
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Table 3-3 Mean percentage of cells (+/- SD) displaying the indicated phenotype after 5
hours treatment with 0.3 µM Latrunculin A (n = 3).
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3.4

Bioinformatical analysis of the adn2 gene

The ultimate goal of the project described in this thesis was to understand the
molecular mechanisms by which the identified genes mitigate the detrimental effects of
abnormal cytoskeletal perturbations. Since a detailed characterization of all of the hits
would be well beyond the scope of a single MSc project, I decided to focus my
attention on a single gene. Due to my interest in transcriptional mechanisms, I chose
the most highly ranked transcription factor from the high-confidence list of hits. The
gene is referred to as adn2 (for adhesion defective).
adn2 was first identified in a functional genomic screen for genes involved in
adhesion, invasion, and mycelial formation (Dodgson et al., 2009).
identified 12 genes required for mycelial development.

This study

Of these 12 genes, two

(including adn2) were defective in the initial adhesion of the cells to the surface of the
growth medium (this represents the first stage of mycelial formation). Little else is
known with respect to the function of the adn2 gene. To begin my analysis of the
functional roles of the encoded gene-product, I made use of available bioinformatical
tools to learn more with respect to its domain structure, its evolutionary relatedness to
other proteins, and its protein interaction network. These analyses are described below.

3.4.1

Domain structure
The Adn2p protein sequence was obtained from Pombase (www.pombase.org/)

and input into the Simple Modular Architecture Research Tool (http://smart.emblheidelberg.de/) with the PFAM domain search box checked. This search identified i) a
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LisH domain, ii) a single stranded DNA binding domain, and iii) two coiled-coil
domains (Figure 3-6).
The LisH motif is found in eukaryotic proteins involved in microtubule
dynamics, cell migration, and chromosome segregation. It is thought that the LisH
domain contributes to the regulation of microtubule dynamics. SSDP defines a singlestranded DNA binding domain with specificity to pyrimidine-rich elements found in the
promoter regions of target genes. Coiled-coils are alpha-helical structures that mediate
subunit oligomerization of a variety of different proteins, including transcription
factors.

The above analysis thus implicated Adn2p in both the regulation of the

microtubule cytoskeleton, and in the regulation of transcription.

3.4.2

Phylogenetic analysis
To determine whether Adn2p defines a conserved family of proteins, the DRSC

Integrative Ortholog Prediction Tool(www.flyrnai.org/cgi-bi n/DRSC_orthologs.pl)
was used to identify related proteins. This analysis revealed that Adn2p was part of a
family of 17 related genes (bearing SSDP domains) present in budding yeast,
Drosophila, mouse, rat, C. elegans, zebrafish and humans. The individual protein
sequences were then obtained and input into the phylogeny.fr phylogeny analysis tool
(www.phylogeny.fr/simple_phylogeny.cgi). This tool uses the MUSCLE algorithm for
multiple alignment, the PHYML algorithm for phylogenetic analysis, and the TreeDyn
algorithm for tree rendering. The results of this analysis are shown in Figure 3-7.
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Figure 3-6 Domain Structure of Adn2p. LisH, Lissencephaly type-1-like homology
motif; SSDP, single stranded DNA binding protein; CC, coiled coil.
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Figure 3-7 Phylogenetic analysis of Adn2p and its related proteins. The MUSCLE
algorithm was used for multiple alignment, the PHYML algorithm for phylogenetic
analysis, and the TreeDyn algorithm for tree rendering. Scale bar, 0.6 amino acid
substitutions per site. Protein sequences were obtained from the NCBI database.
Bootstrap value =1000.
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This analysis revealed that the closest ortholog of Adn2p was the budding yeast,
FLO8 protein, but that significant sequence divergence had occurred over evolutionary
time. Similarity between Adn2p and its metazoan orthologs is restricted to the SSDP
domain.

With the exception of FLO8 (required for flocculation), and SAM-10

(required for presynaptic differentiation and neurite branching) little is known with
respect to the biological functions of the related proteins (Kim et al., 2014; Zheng et al.,
2011).

3.4.3

Protein interaction network
To explore the protein interaction network surrounding Adn2p, the BioGrid

database (thebiogrid.org/) was queried to identify Adn2p binding partners.

This

analysis revealed a small interactome of only three proteins, the alpha-importin, Imp1p,
the

phosphatidylinositol-3-phosphate

binding

protein,

SPAC6F6.12,

and

the

uncharacterized, SPBC354.04 (Figure 3-8). Interestingly, two of the three interactors
(imp1 and SPAC6F6.12) were also identified as hits in our original screen for LatA
sensitive mutants. Thus, Adn2p might be part of a multi-protein complex with roles in
defending against cytoskeletal perturbations (see Discussion).
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Figure 3-8 Protein interaction network of the Adn2p protein. Interaction data was
obtained from the BioGrid database (thebiogrid.org/). The network was visualized
using EsyN (www.esyn.org).
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3.5

Live-cell imaging of cytokinesis in adn2Δ mutants

To obtain more detailed information (in real-time) as to the effects of adn2 loss
of function mutations on the process of cytokinesis in S. pombe, I imaged adn2Δ strains
expressing the Rlc1-GFP fusion protein. rlc1 encodes for the myosin II regulatory light
chain and thus serves as an excellent marker for visualizing constriction of the
actomysin ring.
I began by examining actomyosin ring constriction in the absence of LatA in
both an adn2Δ strain and a wild-type control. In the presence of DMSO (solvent
control), both the wild-type strain (Figure 3-9A) and the adn2Δ strain (Figure 3-9B)
were able to successfully complete cytokinesis within 30-35 minutes. When treated
with 0.2 μM LatA, the wild-type strain was able to constrict the actomyosin ring,
however, where it took approximately 30-35 minutes under control conditions, it took
about 70 minutes for cells to complete cytokinesis in the presence of LatA (Figure 39C). This is due to the cell being held in a prolonged cytokinesis competent state,
characterized by continuous repair/reestablishment of the actomyosin ring.
When treated with 0.2 μM LatA the adn2Δ strain was unable to successfully
constrict the actomyosin ring (Figure 3-9D). While the actomyosin ring was able to
form, GFP expression became progressively weaker over time and the ring was
eventually lost (without constricting) after 30-35 minutes. This suggests that Adn2p,
while not required for ring assembly, is essential for proper ring maintenance and
constriction upon perturbation of the cytokinetic machinery in response to LatA
induced stress.
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Figure 3-9 adn2Δ mutants are unable to constrict the actomyosin ring when
treated with LatA. Wild-type and adn2Δ cells expressing Rlc1p-GFP were grown
overnight to mid-log phase in YES media. The strains were then imaged in real time by
fluorescence microscopy using the GFP filter. A) Wild-type cells treated with DMSO.
B) adn2Δ cells treated with DMSO. C) Wild-type cells treated with 0.2 Μm LatA. D)
adn2Δ cells treated with 0.2 μM LatA. Time in minutes is indicated at the bottom right
of each image.
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3.6

Over-expression analysis of the adn2 gene

Up to this point, my studies had clearly shown that the loss of adn2 results in
cytokinetic defects when cells are challenged with LatA. To determine the effects of
Adn2p over-expression I created three different expression constructs (pREP1-adn2,
pREP41-adn2, and pREP81-adn2) in which adn2 was under the respective control of
one of three thiamine repressible nmt promoters: nmt1(strong overexpression), nmt41
(moderate overexpression) and nmt81 (low overexpression) (Basi et., 1993). The overexpression strains were grown in liquid EMM medium in both the presence or absence
of thiamine, to mid-log phase. Cells from each culture were then treated with DMSO
or 0.1 μM, 0.2 μM, or 0.3 μM LatA, and grown for a further 5 hours. Cells were then
fixed with ethanol, stained with DAPI/aniline blue, and visualized using fluorescence
microscopy (Figure 3-10).
Interestingly, strains with the highest level of Adn2p overexpression (pREP1adn2) grown in the absence of thiamine showed phenotypic abnormalities that included
fragmented septa, tetranucleate cells and multiple septa (Figure 3-10, arrows). In
contrast, strains with low/moderate levels of Adn2p overexpression (grown either in the
presence or absence of thiamine) did not show any of these cellular phenotypes. These
data suggest that Adn2p overexpression has a dominant negative effect leading to
cytokinetic abnormalities (see Discussion).
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Figure 3-10: Cell nucleus and wall/septum staining of strains over-expressing
adn2. Adn2p overexpression plasmids were treated with 0.3 µM LatA or DMSO for 5
hours. Overexpression was repressed by adding thiamine to LatA and DMSO cultures,
to act as repressed controls. To visualize the cell nucleus and wall/septum, cells were
stained with DAPI (nucleus) and aniline blue (wall/septum). Cells were visualized with
fluorescence microscopy using a DAPI filter. Arrows point to cells with multiple
septa.
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3.7 Intracellular localization of Adn2-GFP
The intracellular localization of a protein often reveals clues as to its functional
role within the cell.

To assess the localization of Adn2p, I constructed a vector

containing the carboxy terminus of adn2 fused in-frame with the GFP coding sequence
(see Materials and Methods). This construct was then homologously integrated at the
adn2 locus creating a strain expressing full length Adn2-GFP fusion proteins under the
control of the native adn2 promoter.
To assess the localization of Adn2p under normal growth conditions, strains
were grown to mid-log phase in YES medium and then observed by live-cell
fluorescence microscopy.

Given its putative role in transcriptional regulation, I

expected Adn2-GFP to localize to the nucleus. As hypothesized, Adn2p did indeed
localize to the nuclear compartment (Figure 3-11). To assess Adn2p localization in
response to cytokinetic stress, cells were grown as before, but treated with 0.2 μM LatA
for five hours.

Adn2p localization was similar to that seen under non-stressed

conditions indicating that Adn2p targeting to the nucleus was not affected by LatA
treatment (data not shown).
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Figure 3-11: Intracellular localization of Adn2p. Adn2p-GFP strains were grown to
mid-log phase in liquid EMM-leucine and visualized by bright field (left) and
fluorescence microscopy (right) using the GFP filter. Intracellular localization of
Adn2p was consistent throughout the cell cycle in both the DMSO treated cells and in
cells treated with LatA.
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Chapter 4
4 Discussion
4.1 Identifying cytokinesis checkpoint genes
As part of this thesis I performed a genome-wide screen to identify genes
involved in the S. pombe cytokinesis checkpoint (Figure 3-1, 3-2). Version 4 of the
Bioneer haploid gene deletion set, which represents ~ 95% of non-essential S. pombe
genes, was used. The screen was based on the use of the actin depolymerizing drug,
Latrunculin A (LatA). LatA is a naturally occurring macrolide toxin produced by the
red sea sponge, Negomabata magnifica (formerly known as Latrunculia magnifica)
(Spector et al., 1983). The drug – which consists of a 16-member lactone ring attached
to a 2-thiazolidinone moiety – acts within living cells by sequestering G-actin, thereby
preventing F-actin assembly (Spector et al., 1983; Coué et al., 1987; Yarmola et al.,
2000).

In vitro studies have shown that LatA binds monomeric actin with a 1:1

stoichiometry and has an equilibrium dissociation constant (Kd) of only ~ 0.2 μM (Coué
et al., 1987; Yarmola et al. 2000). When used at high concentrations that are well
above its Kd (i.e. 10-50 μM), it is effective in completely disrupting the actin
cytoskeleton over a time-frame of minutes (Ayscough, 1998).
While typically used at high concentrations, LatA has also been used at much
lower levels (i.e. near the equilibrium constant of 0.2 μM) to mildly perturb the actin
cytoskeleton (Coué et al., 1987). In fission yeast, for example, such low dose treatment
disrupts the cell division machinery leading to the activation of a cytokinesis
checkpoint system (Mishra et al., 2004). This system promotes the establishment of a
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cytokinesis competent state characterized by delayed progression into mitosis and the
continuous repair and/or re-establishment of the cytokinetic actomyosin ring (reviewed
in Karagiannis, 2012). I was thus able to use low dose LatA treatment as an effective
tool to perturb the cell division machinery and isolate mutants defective in the
cytokinesis checkpoint response. Two mutants previously shown to be hyper-sensitive
to LatA (lsk1Δand pap1Δ), as well as a wild-type strain, were employed in the screen
as positive and negative controls, respectively, to ensure LatA dosage was in the proper
range to isolate checkpoint mutants.

4.2 Hypersensitive mutants show varying degrees of
sensitivity to LatA
Having identified strains that show a hypersensitive phenotype in response to
LatA, I next wanted to further characterize each mutant’s sensitivity to the drug .I
performed a series of ten-fold serial dilutions to gauge each mutant’s sensitivity to
LatA. Sensitivity ranged from mild (capable of growth in 0.3 μM LatA) to severe
(incapable of growth in 0.1 μM LatA) within the group of 38 high confidence hits
(Figure 3-3).

Next, to provide a quantitative assessment of LatA sensitivity,I

performed disk diffusion assays where the zone of inhibition for each strain was
determined, and used to create a ranked list of the mutants according to their degree of
sensitivity to LatA (Figure 3-4, Table 3-1).

Lastly, the minimum inhibitory

concentration (the lowest concentration of LatA that prevented visible colony growth)
was determined for each of the 38 strains (Table 3-2).

The minimum inhibitory

concentration varied from 0.2 μM for wild type to 0.025 μM for the most sensitive
mutants.
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Based on this last result I conclude that LatA tolerance is genetically controlled
over at least an 8-fold range in S. pombe. Importantly, while clear that the identified
mutants display growth defects in the presence of the drug, they are nonetheless fully
capable of growth and cell division when not stressed (i.e. when grown in the presence
of the solvent control, DMSO). These results strongly suggest that fission yeast employ
a diverse set of regulatory modules to actively counter cytoskeletal perturbations,
thereby ensuring cell survival and proliferation.
It is also clear that these diverse regulatory modules represent a wide-ranging
array of biological functions (Appendix A).

While genes involved in regulating

cytokinesis and/or the actin cytoskeleton are indeed represented (e.g. the alpha-actinin
gene, ain1, the F-actin capping subunit, acp2, and the contractile ring protein, imp2) (Li
et al., 2016; Nakano and Mabuchi, 2006; Ren et al., 2015), other functions, ranging
from histone modification to intracellular transport to glucose mediated signaling are
also implicated. How these modules interact and communicate to create a cellular state
conducive to cytokinesis remains to be determined and will undoubtedly require further
experimentation using a broad, multidisciplinary, and systems-based approach. Since
such a detailed characterization would be well beyond the scope of a single MSc
project, I next decided to focus on a single gene. Due to my interest in transcriptional
control, I selected the most highly ranked transcription factor from the high-confidence
list of hits, adn2 (for adhesion defective).
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4.3 Adn2p is required for ring constriction upon LatA
treatment
My initial assays demonstrated that the adn2Δ mutant was defective in
cytokinesis, however the assays did not show why cell division failed. Since one of the
responses of the cytokinetic monitoring system is to stabilize the actomyosin ring, I
observed actomyosin ring dynamics in adn2Δ mutants (Figure 3-9). To observe ring
constriction I used strains expressing the Rlc1p-GFP fusion protein. Rlc1p is a myosin
regulatory light chain that binds two Type II myosin heavy chains, which are
responsible for ring formation. Therefore Rlc1p-GFP fusion proteins can be used to
monitor actomyosin ring constriction in live cells and in real time.
Upon treatment with DMSO, both adn2Δ cells and wild-type cells displayed
similar ring constriction kinetics, taking on average 30-35 minutes to assemble and
constrict the actomyosin ring. Upon treatment with 0.2 µM LatA, wild-type cells were
still able to assemble and constrict the ring, however this occurred over a longer period
of time, taking about 70 minutes to complete. When treated with LatA, the mutant
adn2Δ displayed different ring dynamics. While able to initially assemble the ring, ring
expression became progressively weaker, and eventually faded from view over a timeframe of 30-35 minutes.

These results suggest that Adn2p is not an essential

component of ring assembly, but is required for proper constriction when the cell
division machinery is perturbed. This phenotype is somewhat in contrast to other LatA
sensitive mutants (e.g. lsk1Δ, clp1Δ) where the ring visibly fragments into multiple
pieces upon LatA treatment (Karagiannis et al., 2005; Mishra et al., 2004). How Adn2p
(or other LatA sensitive mutants) affect actomyosin ring structure and constriction
remains unknown and will be the subject of future research. Considering Adn2p’s role
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as a transcription factor, it would be interesting to use gene expression profiling (+/LatA) to determine whether adn2Δ mutants display defects in the expression of genes
involved in actin ring assembly or constriction.

4.4 The Adn2p transcription factor localizes to the
nucleus
Since adn2 is a predicted transcription factor, I hypothesized that Adn2p would
localize to the nucleus. To assess localization, I transformed a plasmid containing the
carboxy terminus of adn2 fused upstream of the GFP coding sequence. This construct
was then homologously integrated at the adn2 locus so that expression was controlled
by the native promoter. As expected, Adn2p was observed to localize to the nucleus
(Figure 3-11).
Interestingly, a previous high throughput study reported that Adn2p localized to
cytoplasmic dots (Matsuyama et al., 2006). However, in the study by Matsuyama et al.
Adn2p was expressed under the control of the strong nmt1 promoter. It is thus possible
that the cytoplasmic dots observed in that study are simply the result of the abnormally
high level of expression leading to the formation of artefactual protein aggregates. It
should be noted that in my study adn2 was expressed under the control of its native
promoter, and thus my results more likely reflect the true localization of the protein in
vivo. The fact that Adn2p is a transcription factor, and must enter the nucleus to
function, also supports the results of my localization studies.
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4.5 Overexpression of And2p results in cytokinetic
abnormalities
To explore the effects of modulating Adn2p dosage on cytokinesis, I overexpressed the protein using the pREP series of expression vectors (Figure 3-10).
Interestingly, cells overexpressing Adn2p via the nmt1 promoter accumulated abnormal
cells with multiple septa, while cells under the control of the weaker nmt41 and nmt81
promoters did not accumulate cells with multiple septa.

This result implies that

overexpression of adn2 results in a dominant-negative effect in which the abnormally
high levels of Adn2p adversely affects the normal functioning of Adn2p and/or its
associated protein partners within the cell and thus giving rise to the abnormal multiseptate phenotype. A dominant-negative effect is also supported by the fact that,
similar to adn2Δ mutants, cells overexpressing Adn2p are hyper-sensitive to LatA (data
not shown). A dominant negative effect is the result of a protein masking the effect of
the wild type endogenous protein, resulting in loss of wild-type protein function and
phenotype. Given the role of Adn2p as a transcription factor, it is possible that the high
levels of Adn2p results in the ectopic expression of target genes involved in cytokinesis
thereby resulting in the improper stoichiometry of the protein complexes governing cell
division. Gene expression profiling (+/- LatA) would be one method by which to
definitively test this hypothesis.

4.6 Adn2p might be part of a multi-protein complex with
roles in defending against cytoskeletal perturbations
The BioGrid database (www.thebiogrid.org/) was queried to identify Adn2p
binding partners. This analysis revealed a small interactome of three proteins: the
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importin-α, Imp1p, autophagy associated protein, Atg24p, and the uncharacterized
protein, SPBC354.04 (Figure 3-8).

Interestingly, two of the genes, imp1 and

atg24were identified as hits in this study. A detailed analysis of the functional role of
each of the three proteins suggests the multi-protein complex might have a role in
defending against cytoskeletal perturbations.
Imp1p is an importin-α that is involved in the import of proteins targeted to the
nucleus. In S. pombe, Imp1p localizes to nuclear pores at the nuclear envelope
throughout the cell cycle and during cell division when the nuclear envelope surrounds
the elongating mitotic spindle (Lucena et al., 2015). Imp1p acts as an adaptor protein,
interacting with cargo proteins in the cytoplasm, linking the cargo protein to an
importin-β, and then migrating into the nucleoplasm through a nuclear pore (Lucena et
al., 2015). S. pombe Imp1p has been shown to interact with the AP-1-like transcription
factor Pap1p, which is involved in multidrug resistance by regulating genes required in
multiple stress response pathways (Umeda et al., 2005). The pap1Δ strain is used in
this study as a positive control as it is a mutant known to be hypersensitive to a wide
variety of toxins and which was observed to be highly sensitive to LatA (Asadi et al.,
2017).

As expected, due to its interaction with Imp1p, Pap1p contains an NLS

sequence (Umeda et al., 2005). Furthermore, Pap1p translocates into the nucleus in an
Imp1p dependent manner (Asadi et al., 2017).

Interestingly, the Adn2p protein

sequence also contains an NLS sequence: KRHKR (Kosugi et al., 2008). It would thus
be interesting to determine whether Adn2p localization to the nucleus is also dependent
on Imp1p.
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Also included in the multi-protein complex is Atg24p. Atg24p belongs to the
Autophagy related (Atg) protein family, members of which are involved in autophagy.
Autophagy has been extensively studied in S. cerevisiae, and many homologs of the
autophagy machinery required in S. cerevisiae have been identified in S. pombe. The
predicted function of atg24 in S. pombe has largely been inferred from sequence
homology with S. cerevisiae Atg24p (Mukaiyama, et al., 2010; Zhao et al., 2016).
Atg24p binds to the membrane phospholipids phosphatidylinositol-3-phosphate via its
PX domain and localizes to membrane structures involved in autophagy. Recently, a
study in S. pombe found that Atg24p localizes to a pre-autophagosomal structure called
the phagophore assembly site (PAS). The study also found that Atg24p is required for
selective autophagy in S. pombe, which targets specific cargos for degradation via
receptor recognition. Specifically, Atg24p is involved in the cytoplasm to vacuole
targeting (Cvt) pathway, which delivers the hydrolase α- aminopeptidase I (Ape1) to
the vacuole (Zhao et al., 2016). This pathway is exclusively found in yeast, and the
exact function of Atg24p in the Cvt pathway in both budding and fission yeast remains
unknown.
The last Adn2p binding partner is the S. pombe specific protein, SPBC354.04.
SPBC354.04is a short, 163 amino acid long protein that is thought to localize to the
cytosol and nucleus (Matsuyama et al., 2006). Interestingly, SPBC354.04 has been
predicted to interact with the autophagy-related proteinAtg11 (Vo et al., 2016). In S.
pombe atg11 is part of the core Cvt machinery, directing receptor bound cargo to the
PAS (Yamasaki A et al., 2017). Interestingly, the process of autophagy has indeed
been linked to successful cytokinesis (Belaid et al., 2013). In this study, the authors
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show that inhibition of autophagosome formation result in cytokinesis failure,
multinucleation, and aneuploidy in mouse renal cells. The possible role of Adn2p in
regulating autophagy, and the role of autophagy in fission yeast cytokinesis, remains
unknown and will require further study.

4.7 Adn2p target genes include cell wall remodeling
enzymes
Adhesion defective protein 2 (Adn2p) was first identified in S. pombe during a
screen for haploid deletion strains unable to invade the growth medium. Invasion of
medium by yeast cells required flocculant growth, a type of cellular growth exhibited
by yeast in which they form elaborate, branched, multicellular structures which deeply
invade the growth medium. Prior to the visible invasion of the medium, cells adhere to
the surface of the medium and become resistant to removal by gentle washing. Adn2Δ
strains were defective in this first step of invasive growth, and did not adhere to the
medium, and based on this phenotype the gene was named adhesion defective protein
(Dodson et al., 2009).
Sequence analysis found that adn2 is orthologous to S. cerevisiae FLO8 (Figure
3-7), a transcription factor required for flocculation and invasive growth. Similar to
FLO8, Adn2p contains a LisH domain, suspected to be required for protein
dimerization (Mateja et al., 2006; Kim et al., 2014). Also found within Adn2p are a
ssDNA binding domain, and two coiled coil domains (Figure 3-6), both of which
further implicate Adn2p as a regulator of transcription.
Since its identification in the flocculation screen performed by Dodgson and
colleagues in 2009, no further characterization of Adn2p was reported in the literature,
until a more recent study by Kwon and colleagues (2012). In their effort to uncover the
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transcriptional-regulatory network of flocculation in S. pombe. the group uncovered
Adn2p as one of the master regulators of flocculation in the fission yeast.
Kwon et al. (2012) observed that adn2 overexpression was sufficient to trigger
flocculation (FLO8 overexpression in budding yeast also triggers flocculation).
However, unlike its budding yeast ortholog, which targets the flocculin genes (FLO1
and FLO11), the flocculent phenotype of Adn2p overexpression is attributed to the
expression of cell-wall remodeling enzymes (Teunissen and Steensma, 1995; Kwon et
al., 2012).

Microarray analysis uncovered that Adn2p overexpression triggers up-

regulation of two cell-wall remodeling enzymes, gas2+ (a glycosyltransferase) and
SPAC4H3.03c (a glycoside hydrolase). Cell wall remodeling is an essential process for
proper growth and adaptation to environmental stresses in yeast cells. Part of the cell
wall remodeling process involves dissolution of sugar moieties in the glucan layer by
glycoside hydrolases and elongation of glucan chains by glycosyltransferases. The role
of gas2+ and SPAC4H3.03c in flocculation may be to restructure the cell wall, which
may result in the rearrangement of flocculins, making them more accessible to cell
surface oligosaccharides (Kwon et al., 2012).
Similar to the multiseptate overexpression phenotype of Adn2p observed in my
study, Kwon et al. (2012) observed the same multisepta phenotype when Adn2p was
overexpressed.

The multisepta phenotype was not observed when gas2+ and

SPAC4H3.03c were overexpressed, suggesting that adn2 may regulate cell separation
and flocculation independently through different sets of target gene. The group further
hypothesizes that Adn2p may control septation via ace2+, a transcriptional activator of
the cell division process, and identified in my study as a low confidence hit (Appendix

58

1).

Therefore, targets of the Adn2p transcription factor include genes controlling

septation as well as cell wall remodeling genes (Kwon et al., 2012). Further work will
need to be done to determine the critical transcriptional targets of Adn2p with respect to
the phenotypes described in this study.

4.8 Future work concerning the role of Adn2p in
defending against cytoskeletal perturbations
In this study, we have shown that Adn2p is necessary for cell survival when
cells are exposed to cytokinetic stress. However, we do not know the mechanism
through which Adn2p ensures the faithful execution of cytokinesis in the presence of
LatA. Identifying the genes that Adn2p regulates in order to ensure the accurate and
reliable execution of cytokinesis would provide insight into the role of Adn2p in the
cytokinesis checkpoint. This could be accomplished through gene expression profiling
of both wild-type and adn2Δ mutant fission yeast in the presence and absence of LatA.
We have shown that Adn2p has a role in defending against cytokinetic stress
during cell division, however, does Adn2p have a role in defending against other
cytoskeletal perturbations? Based on the individual gene functions of the predicted
Adn2p interactome, Adn2p may be involved in defending against cytoskeletal
perturbation in the Cvt pathway. Further experiments are needed to confirm the Adn2p
interactome. A co-immunoprecipitation assay could confirm if the predicted
interactome exists in vivo, however if the interactome is only required for the Cvt
pathway, it may be difficult to isolate, as little is known about the cellular conditions
required to induce the Cvt pathway in vitro.
We have shown that Adn2p is required for the execution of cytokinesis in the
presence of LatA.

Adn2p has also been implicated in surface adhesion during
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flocculation (Dodgson et al., 2009) and as a transcriptional activator of cell wall
remodeling enzymes (Kwon et al., 2012). With this emerging set of diverse cellular
functions, Adn2p is a protein that warrants further investigation and will contribute to
our overall understanding of multiple cellular processes in S. pombe.
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Appendices
Appendix A: Complete list of LatA sensitive gene deletion mutants identified via
genome-wide screening. “Y” indicates that the gene was hit in a given trial of the
screen. “n” indicates that the gene was not hit in a given trial of the screen.

Systemic ID

Gene description

Trial
#1

Trial
#2

Trial
#3

Confidence

SPAC15A10.08

alpha-actinin

Y

Y

Y

High

SPAC167.01

Ppk4 sensor

Y

Y

Y

High

SPAC17A5.14

exonuclease II Exo2

Y

Y

Y

High

SPAC19A8.04

C-22 sterol desaturase Erg5

Y

Y

Y

High

SPAC3H8.08c

transcription factor (predicted)

Y

Y

Y

High

SPAC4G9.14

Mvp17/PMP22 family protein 2

Y

Y

Y

High

SPAC57A7.04c

mRNA export shuttling protein

Y

Y

Y

High

SPAC630.14c

transcriptional corepressor Tup12

Y

Y

Y

High

SPAC631.01c

F-actin capping protein beta subunit

Y

Y

Y

High

SPAC688.11

Huntingtin-interacting protein homolog

Y

Y

Y

High

SPAC6F6.01

calcium channel Cch1

Y

Y

Y

High

SPAC869.11

cationic amino acid transporter Cat1

Y

Y

Y

High

SPAC9.02c

polyamine N-acetyltransferase

Y

Y

Y

High

SPBC106.10

Pka1

Y

Y

Y

High

SPBC11C11.02

contractile ring protein Imp2

Y

Y

Y

High

SPBC1289.10c

transcription factor (predicted)

Y

Y

Y

High

SPBC19C7.01

Mago binding protein homolog

Y

Y

Y

High

SPBC215.04

Git11

Y

Y

Y

High

SPBC28F2.10c

SAGA complex subunit Ngg1

Y

Y

Y

High

SPBC3D6.02

But2 family protein But2

Y

Y

Y

High

SPBC4F6.06

Kin1

Y

Y

Y

High

SPBP16F5.03c

Tra1

Y

Y

Y

High

SPCC1020.07

haloacid dehalogenase-like hydrolase

Y

Y

Y

High

SPCC1753.02c

G-protein coupled receptor Git3

Y

Y

Y

High

SPCC4F11.03c

sequence orphan

Y

Y

Y

High

SPCC645.08c

RNA-binding protein Snd1

Y

Y

Y

High

SPCC70.06

nuclear export factor

Y

Y

Y

High

SPCC794.08

HEAT repeat protein

Y

Y

Y

High

SPAC16C9.06c

ATP-dependent RNA helicase Upf1

Y

Y

Y

High

SPAC3C7.07c

arginine-tRNA protein transferase

Y

Y

Y

High

SPBC13G1.03c

peroxisomal docking protein Pex14

Y

Y

Y

High

SPBC32H8.07

Git5

Y

Y

Y

High

SPBC651.11c

AP-3 adaptor complex subunit Apm3

Y

Y

Y

High

SPBC725.10

tspO homolog

Y

Y

Y

High
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SPCC162.10

serine/threonine protein kinase Ppk33

Y

Y

Y

High

SPCC285.09c

cAMP-specific phosphodiesterase Cgs2

Y

Y

Y

High

SPCC297.05

diacylglycerol binding protein

Y

Y

Y

High

SPCC794.03

amino acid permease (predicted)

Y

Y

Y

High

SPAC12B10.07

F-actin capping protein alpha subunit

Y

n

Y

Medium

SPAC13C5.04

amidotransferase (predicted)

n

Y

Y

Medium

SPAC144.06

AP-3 adaptor complex subunit Apl5

Y

n

Y

Medium

SPAC1952.05

Gcn5

Y

n

Y

Medium

SPAC19B12.10

human AMSH/STAMBP protein homolog

n

Y

Y

Medium

SPAC19E9.02

NIMA related Fin1

Y

n

Y

Medium

SPAC1D4.03c

autophagy associated protein Aut12

Y

n

Y

Medium

SPAC227.10

prefoldin subunit 2

Y

n

Y

Medium

SPAC22A12.04c

40S ribosomal protein S15a

Y

n

Y

Medium

SPAC22E12.11c

Set3

Y

n

Y

Medium

SPAC23A1.11

60S ribosomal protein L13/L16

n

Y

Y

Medium

SPAC23H3.13c

Gpa2

Y

n

Y

Medium

SPAC24B11.12c

P-type ATPase

Y

n

Y

Medium

SPAC26A3.04

60S ribosomal protein L20

Y

Y

n

Medium

SPAC26A3.06

rRNA (guanine) methyltransferase

Y

n

Y

Medium

SPAC26A3.16

UBA domain protein Dph1

Y

n

Y

Medium

SPAC26F1.04c

enoyl-[acyl-carrier protein] reductase

Y

n

Y

Medium

SPAC27E2.03c

GTP binding protein

n

Y

Y

Medium

SPAC29A4.20

Elp3

Y

n

Y

Medium

SPAC29B12.08

sequence orphan

Y

n

Y

Medium

SPAC30.02c

Kti2

Y

n

Y

Medium

SPAC30D11.05

Aps3

Y

n

Y

Medium

SPAC31A2.16

RhoGEF Gef2

Y

n

Y

Medium

SPAC31G5.19

ATPase with bromodomain protein

Y

n

Y

Medium

SPAC323.04

mitochondrial ATPase

n

Y

Y

Medium

SPAC328.10c

40S ribosomal protein S5

Y

n

Y

Medium

SPAC4C5.02c

GTPase Ryh1

Y

n

Y

Medium

SPAC6F6.12

autophagy associated protein Atg24

Y

n

Y

Medium

SPAC8E11.02c

14-3-3 protein Rad24

Y

n

Y

Medium

SPAC959.08

60S ribosomal protein L21

Y

n

Y

Medium

SPAPB17E12.03

ubiquitin-protein ligase E3

Y

n

Y

Medium

SPAPB1E7.02c

Mcl1

n

Y

Y

Medium

SPBC1105.04c

CENP-B homolog

Y

n

Y

Medium

SPBC119.08

MAP kinase Pmk1

Y

n

Y

Medium

SPBC11B10.07c

CDC50 domain protein

Y

n

Y

Medium

SPBC11C11.08

SR family protein Srp1

Y

n

Y

Medium

SPBC1271.12

oxysterol binding protein

Y

n

Y

Medium

SPBC12C2.02c

Rictor homolog, Ste20

Y

n

Y

Medium

SPBC14F5.09c

adenylosuccinate lyase Ade8

n

Y

Y

Medium
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SPBC1604.08c

vacuolar
membrane
phosphatase
importin alpha

SPBC16H5.08c

Arb family ABCF2-like

Y

n

Y

Medium

SPBC1861.09

Ppk22

Y

n

Y

Medium

SPBC1921.04c

dubious

Y

n

Y

Medium

SPBC19G7.10c

topoisomerase II-associated

Y

n

Y

Medium

SPBC23E6.01c

mRNA processing factor

Y

Y

n

Medium

SPBC28F2.02

mRNA export protein Mep33

Y

n

Y

Medium

SPBC29A10.16c

cytochrome b5 (predicted)

n

Y

Y

Medium

SPBC36.07

elongator subunit Iki3

Y

n

Y

Medium

SPBC3H7.10

Y

n

Y

Medium

Y

n

Y

Medium

SPBC609.04

elongator complex subunit Elp6
histone deacetylase complex subunit
Rxt2
Caf5

Y

n

Y

Medium

SPBC646.09c

eIF3e subunit Int6

Y

n

Y

Medium

SPBC902.03

Spo7

Y

n

Y

Medium

SPBC947.08c

histone promoter control protein

n

Y

Y

Medium

SPBP8B7.22

HDEL receptor

n

Y

Y

Medium

SPCC11E10.06c

elongator complex subunit Elp4

Y

n

Y

Medium

SPCC1235.09

Set3 complex subunit Hif2

Y

n

Y

Medium

SPCC1235.11

human BRP44L ortholog

Y

Y

n

Medium

SPCC14G10.03c

Ump1

Y

n

Y

Medium

SPCC24B10.08c

Ada2

Y

Y

n

Medium

SPCC24B10.11c

THO complex subunit 7

n

Y

Y

Medium

SPCC4B3.15

medial ring protein Mid1

Y

n

Y

Medium

SPCC645.07

RhoGEF for Rho1, Rgf1

n

Y

Y

Medium

SPCC794.12c

malic enzyme, Mae2

Y

Y

n

Medium

SPAC1782.09c

Clp1/Flp1

Y

n

Y

Medium

SPAC2E1P3.04

copper amine oxidase Cao1

n

Y

Y

Medium

SPBC16A3.08c

Stm1 homolog (predicted)

Y

n

Y

Medium

SPBC18H10.09

zf-CHY type zinc finger protein

Y

n

Y

Medium

SPBC215.02

prefoldin subunit 5 (predicted)

Y

n

Y

Medium

SPBC21B10.10

40S ribosomal protein S4 (predicted)

Y

n

Y

Medium

SPBC31F10.09c

mediator complex subunit Med10

Y

n

Y

Medium

SPBC3H7.03c

2-oxoglutarate dehydrogenase

n

Y

Y

Medium

SPCC1259.01c

40S ribosomal protein S18

n

Y

Y

Medium

SPCC364.03

60S ribosomal protein L17

n

Y

Y

Medium

SPCC4B3.08

Lsk1 complex gamma subunit

Y

Y

n

Medium

SPCC584.11c

Svf1 family protein Svf1

Y

n

Y

Medium

SPAC1002.07c

N-acetyltransferase Ats1

n

n

Y

Low

SPAC1071.07c

40S ribosomal protein S15

n

Y

n

Low

SPAC110.02

cohesin-associated protein Pds5

n

Y

n

Low

SPAC1142.07c

vacuolar sorting protein Vps32

n

Y

n

Low

SPAC1142.08

fork head transcription factor Fhl1

n

Y

n

Low

SPBC14F5.13c

SPBC428.06c

alkaline

Y

n

Y

Medium

Y

n

Y

Medium
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SPAC11G7.02

Pub1

n

SPAC12G12.12

NST UDP-galactose transporter

SPAC139.01c

nuclease, XP-G family

SPAC1399.03
SPAC13A11.04c
SPAC13F5.03c

n

Y

Low

n

n

Y

Low

n

Y

n

Low

uracil permease

n

Y

n

Low

Ubp8

n

n

Y

Low

Gld1

n

Y

n

Low

SPAC13G6.10c

cell wall protein Asl1

n

n

Y

Low

SPAC13G7.11

mitochondrial assembly protein

n

n

Y

Low

SPAC13G7.12c

choline kinase

n

n

Y

Low

SPAC1486.01

manganese superoxide dismutase

n

n

Y

Low

SPAC14C4.16

DASH complex subunit Dad3

n

n

Y

Low

SPAC1527.01

alpha-1,3-glucan synthase Mok11

n

n

Y

Low

SPAC1565.07c

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

SPAC1687.17c

TATA-binding protein
actin interacting protein 3 homolog
Bud6
dihydroorotase Ura2 (predicted)
mitochondrial ribosomal protein subunit
L1
Der1-like (degradation in the ER) family

n

Y

n

Low

SPAC16A10.02

transcription coactivator PC4

n

n

Y

Low

SPAC1782.05

phosphotyrosyl phosphatase activator

Y

n

n

Low

SPAC1783.07c

transcription factor Pap1/Caf3

Y

n

n

Low

SPAC17A2.11

sequence orphan

n

n

Y

Low

SPAC17A2.12

ATP-dependent DNA helicase

n

n

Y

Low

SPAC17G8.06c

dihydroxy-acid dehydratase

n

Y

n

Low

SPAC18B11.11

GTPase activating protein

n

Y

n

Low

SPAC18G6.15

EB1 family Mal3

n

Y

n

Low

SPAC1952.17c

GTPase activating protein

n

n

Y

Low

SPAC19A8.05c

Sst4

n

n

Y

Low

Pms1

Y

n

n

Low

Tpp1

n

n

Y

Low

n

Y

n

Low

Y

n

n

Low

SPAC15A10.16
SPAC16.03c
SPAC1610.02c

SPAC19G12.02c
SPAC19G12.15c
SPAC19G12.16c
SPAC1A6.01c

conserved fungal protein Adg2
transcription coactivator

SPAC1A6.04c

phospholipase B homolog Plb1

n

n

Y

Low

SPAC1B3.05

Not3/5 (predicted)

n

Y

n

Low

SPAC1B3.07c

Vps28

n

n

Y

Low

SPAC1F5.07c

protoporphyrinogen oxidase

n

Y

n

Low

SPAC1F5.10

eIF4A related

Y

n

n

Low

SPAC1F7.12

YakC

n

n

Y

Low

SPAC20H4.03c

TFIIS

n

n

Y

Low

SPAC227.05

prefoldin subunit 4

n

n

Y

Low

SPAC22F3.10c

glutamate-cysteine ligase Gcs1

n

Y

n

Low

SPAC22F8.02c

PvGal biosynthesis protein Pvg5

n

n

Y

Low

SPAC22G7.11c

conserved fungal protein

n

Y

n

Low

n

Y

n

Low

SPAC23C11.15

Pst2
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SPAC23G3.08c
SPAC23H3.06

Ubp7

n

pl6

n

Y

Low

n

n

Y

Low

SPAC24B11.13

hydroxymethylbilane synthase

n

Y

n

Low

SPAC24H6.07

40S ribosomal protein S9

Y

n

n

Low

SPAC25H1.02

histone demethylase Jmj1

n

n

Y

Low

SPAC26F1.10c

tyrosine phosphatase Pyp1

n

n

Y

Low

SPAC29A4.19c

Cta5

n

n

Y

Low

SPAC29E6.01

F-box protein Pof11

n

n

Y

Low

SPAC2F3.12c

human TXNDC9 ortholog

SPAC2F3.15

Lsk1

n

n

Y

Low

Y

n

n

Low

SPAC2F7.08c

SWI/SNF complex subunit Snf5

Y

n

n

Low

SPAC30.01c

ARF GEF Sec72

n

n

Y

Low

SPAC30C2.02

deoxyhypusine hydroxylase

n

n

Y

Low

SPAC31A2.06

Atp25 (predicted)

n

n

Y

Low

SPAC31A2.09c

AP-2 adaptor complex subunit Apm4

n

Y

n

Low

SPAC31G5.03

40S ribosomal protein S11

n

Y

n

Low

SPAC3C7.01c

inositol polyphosphate phosphatase

n

n

Y

Low

SPAC3C7.08c

AAA family ATPase Elf1

Y

n

n

Low

SPAC3G9.07c

histone deacetylase (class I) Hos2

Y

n

n

Low

SPAC3A11.05c

meiotic spindle pole body protein Kms1

n

n

Y

Low

SPAC3H8.02

sec14

n

n

Y

Low

SPAC3H8.07c

prefoldin subunit 3

n

n

Y

Low

n

n

Y

Low

SPAC4G8.13c

rz1

SPAC57A7.12

heat shock protein Pdr13

Y

n

n

Low

SPAC688.06c

structure-specific endonuclease subunit

Y

n

n

Low

SPAC6G10.12c

transcription factor Ace2

Y

n

n

Low

SPAC7D4.12c

DUF1212 family protein

Y

n

n

Low

SPAC821.05

translation initiation factor eIF3h (p40)

n

n

Y

Low

SPAC824.02

Y

n

n

Low

n

n

Y

Low

SPAC8E11.01c

GPI inositol deacylase (predicted)
rRNA
processing
protein
Fyv7
(predicted)
beta-fructofuranosidase (predicted)

n

Y

n

Low

SPAC8E11.05c

conserved fungal protein

n

n

Y

Low

SPAC9G1.05

actin cortical patch component Aip1

n

n

Y

Low

SPAP8A3.07c

aldolase

Y

n

n

Low

SPAPYUG7.02c

Sin1

n

Y

n

Low

SPBC12C2.07c

Y

n

n

Low

Y

n

n

Low

SPBC1347.13c

spermidine synthase (predicted)
deoxycytidyl
transferase
Rev1
(predicted)
ribose methyltransferase (predicted)

Y

n

n

Low

SPBC1348.14c

hexose transporter Ght7 (predicted)

n

Y

n

Low

SPBC13E7.08c

Paf1 complex

n

n

Y

Low

SPBC146.13c

myosin type I

Y

n

n

Low

SPBC14C8.17c

SAGA complex subunit Spt8

Y

n

n

Low

SPBC1685.02c

40S ribosomal protein S12 (predicted)

n

n

Y

Low

SPAC8C9.07

SPBC1347.01c

72

SPBC16A3.19

Eaf7

n

Y

n

Low

SPBC16C6.09

protein O-mannosyltransferase Ogm4

Y

SPBC16H5.03c

Fub2

n

n

n

Low

n

Y

Low

SPBC16H5.06

ubiquinol-cytochrome subunit 5

n

Y

n

Low

SPBC1718.01

cullin 1 adaptor protein Pop1

n

n

Y

Low

SPBC1734.12c
SPBC18H10.10c

Alg12

n

n

Y

Low

Saf4

Y

n

n

Low

SPBC18H10.14

40S ribosomal protein S16 (predicted)

Y

n

n

Low

SPBC1A4.09

pseudouridine synthase (predicted)

n

n

Y

Low

SPBC1D7.03

cyclin Clg1 (predicted)

n

n

Y

Low

SPBC21.05c

Ras1-Scd pathway protein Ral2

Y

n

n

Low

SPBC21C3.13

40S ribosomal protein S19 (predicted)

n

Y

n

Low

SPBC23E6.08

Y

n

n

Low

n

n

Y

Low

SPBC25D12.02c

Sat1
Rho-type GTPase activating
Rga7
nucleolar protein Dnt1

Y

n

n

Low

SPBC25H2.15

Tsr4 homolog 1

n

Y

n

Low

SPBC27.08c

sulfate adenylyltransferase

n

n

Y

Low

SPBC27B12.11c

transcription factor (predicted)

Y

n

n

Low

SPBC2G2.01c

n

n

Y

Low

Y

n

n

Low

SPBC2G5.06c

pantothenate transporter Liz1
translocon
beta
subunit
(predicted)
sulfide-quinone oxidoreductase

n

n

Y

Low

SPBC317.01

Pvg4

n

n

Y

Low

SPBC31F10.10c

zf-MYND type zinc finger protein

Y

n

n

Low

SPBC32F12.08c

DASH complex subunit Duo1

n

n

Y

Low

Efc25

n

n

Y

Low

SPBC336.14c

Ppk26

n

n

Y

Low

SPBC359.06

adducin

n

n

Y

Low

SPBC36.06c

farnesyl pyrophosphate synthetase

n

n

Y

Low

SPBC365.13c

Ran GTPase binding protein Hba1

n

n

Y

Low

SPBC3B8.10c

Nem1

n

n

Y

Low

n

n

Y

Low

SPBC23G7.08c

SPBC2G2.03c

SPBC336.03

SPBC530.06c

protein

Sbh1

eIF3 alpha subunit (p135)

SPBC685.06

40S ribosomal protein S0A (p40)

Y

n

n

Low

SPBC725.09c

Y

n

n

Low

n

n

Y

Low

SPBC800.04c

BAR adaptor protein Hob3
rRNA
processing
protein
Rrp7
(predicted)
60S ribosomal protein L37a (predicted)

n

Y

n

Low

SPBC800.07c

Tsf1

n

Y

n

Low

SPBP22H7.08

40S ribosomal protein S10 (predicted)

n

Y

n

Low

SPBP35G2.07

acetolactate synthase catalytic subunit

n

n

Y

Low

SPBPB2B2.10c

Gal7

n

n

Y

Low

SPCC1442.02

kinetochore associated

n

n

Y

Low

SPCC14G10.04

sequence orphan

n

n

Y

Low

SPCC1840.10

Lsm8

n

n

Y

Low

SPBC776.17
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SPCC188.07

telomere maintenance protein Ccq1

Y

n

n

Low

SPCC1906.02c

CUE domain protein Cue3

SPCC23B6.01c

SPCC31H12.08c

oxysterol binding protein
adenylyl cyclase-associated
Cap1
Ccr4

Y

n

n

Low

n

Y

n

Low

Y

n

n

Low

n

Y

n

Low

SPCC320.03

transcription factor (predicted)

n

n

Y

Low

SPCC576.12c

FANCM-MHF complex subunit Mhf2

n

n

Y

Low

SPCC794.07

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

n

n

Y

Low

SPAC1556.01c

Lat1
calcineurin
regulatory
subunit
(predicted)
formin For3
20S proteasome component alpha 3
(predicted)
Cox16
poly(A)
binding
protein
Nab2
(predicted)
DNA repair protein Rad50

n

n

Y

Low

SPAC17D4.04

tRNA methyltransferase

n

n

Y

Low

SPAC1805.07c

DASH complex subunit Dad2

n

n

Y

Low

SPAC19B12.04

40S ribosomal protein S30 (predicted)

n

n

Y

Low

SPAC20G4.07c

C-24(28) sterol reductase Sts1

n

Y

n

Low

SPAC22E12.19

Set3 complex subunit Snt1

Y

n

n

Low

SPAC23C11.04c

DNA kinase/phosphatase Pnk1

n

n

Y

Low

SPAC23C4.12

n

n

Y

Low

n

n

Y

Low

Y

n

n

Low

Y

n

n

Low

SPAC2F7.04

serine/threonine protein kinase Hhp2
ornithine
N5
monooxygenase
(predicted)
threonine aldolase Gly1 (predicted)
tRNA-pseudouridine
synthase
(predicted)
mediator complex subunit Pmc2/Med1

n

n

Y

Low

SPAC3A11.08

cullin 4

n

n

Y

Low

SPAC3A11.13

prefoldin subunit 6 (predicted)

n

n

Y

Low

SPAC3C7.06c

n

n

Y

Low

n

n

Y

Low

SPAC513.03

Pit1
SAGA
complex
subunit
(predicted)
M-factor precursor Mfm2

n

Y

n

Low

SPBC1921.07c

SAGA complex subunit Sgf29 (predicted)

Y

n

n

Low

SPBC29A3.21

sequence orphan

Y

n

n

Low

SPBC3H7.05c

sequence orphan

Y

n

n

Low

SPBC725.02

Mpr1

n

n

Y

Low

SPBC839.04

60S ribosomal protein L8

n

n

Y

Low

SPCC1450.05c

mediator complex subunit Med19/Rox3

n

n

Y

Low

SPCC364.05

GTPase regulator Vps3 (predicted)

n

Y

n

Low

SPCC550.12

actin-like protein Arp6

n

n

Y

Low

SPCC63.02c

alpha-amylase homolog Aah3

n

n

Y

Low

SPCPB16A4.04c

Trm8

n

n

Y

Low

SPCC306.09c

SPCC830.06
SPCC895.05
SPAC13C5.01c
SPAC1486.08
SPAC14C4.06c

SPAC23G3.03
SPAC23H3.09c
SPAC25B8.05

SPAC4D7.10c

protein

Spt20
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Appendix B: CLUSTAL O (1.2.4) multiple sequence alignment
FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

--------------------------------------------------------------------------------------------------------SPCcMADPGLRSGVG
-------------MDPQYPDE------------SF--------LFQPRGGPPPG---G-P
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MQGLTSEPATEPRRAPQWEAGTVPPGERRRLAQSLSQKVEGSERASPACWPSGN---GIG
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

--------------TAENSDLKEKMNCKNTLNEYIFDF---LTKSSLKNTAAAFAQDAHLPSQQGQKHDLQKDQKQPHVNNADRTTQSLLNSYIYDY---LIKKDYCEAARAFGREA-QDVPLQS-MPPQAIQQQQQSLASEMIARDRLEHIVKHVKKYPFNCPYCRRLFASQKEVDG
--------MPPQVIQQQQQSLASEMTARDRLTSYIYEY---LQQ------TG-ASK-------------MYGK-SKTSAVPSDAQAREKLALYVYEY---LLH------VG-AQK-------------MYAK-GK-SSVPSDSQAREKLALYVYEY---LLH------VG-AQK-------------MYAK-GKSNNVPSDSQAREKLALYVYEY---LLH------VG-AQK---ATPQTGG-MRST-A-GNGAGSLAGEERERRLALYVYEY---LLH------VG-AQK-----------MYGKGK-SNSSAVPSDSQAREKLALYVYEY---LLH------VG-AQK-----------MYGKGK-SNSSAVPSDSQAREKLALYVYEY---LLH------VG-AQK-------------MYAKGGKGSAVPSDSQAREKLALYVYEY---LLH------IG-AQK-------------MYGKASKG-CAPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MYGKASKG-CAPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MFPK-GKSSVVPSDGQAREKLALYVYEY---LLH------IG-AQK-------------MFAK-GKGTAVPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MFAK-GKGSAVPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MFAK-GKGSAVPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MFAK-GKGSAVPSDGQAREKLALYVYEY---LLH------VG-AQK-------------MYAK-GKGAVVPSDSQAREKLALYVYEY---LLH------VG-AQK-------------MYAK-GKGAVVPSDSQAREKLALYVYEY---LLH------VG-AQK---:
. *
: .
:
:

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

----LD-----------RDKGQNPVD------------GPKSKENNGNQNTF-------QVQTLVRSQEETNSLAKRHKRMSPVAVKHEGISNNESSDENMNVNNGNLDSFSSSSAPPP
HQENRHAE--------LDWKSVEPFAEEEQ-IYRRS-----------------RSIYEES
TAETFKEE--------VLSTNPAA---------------------------------GLA
AAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK--------------------------------------SAQTFLSE--------IRWEK---------------------------------------

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN

--SKVVDTPQGFLYEW*QIFWDIFNTSSSRGGSEFAQQYYQLVLQEQRQEQIYRSLAVHPPILPIDSAGGFLIEWWNVFWDIYNARRGQGSEP-AKAYMSHIS-NLRK---KSRLNLQE
KRNIKNGKPEGYQKSSSVD--------KDTKMTL-SH----------------------AANSTKLSDKSFLLEWWLLFWDLYSAAPERRDAG-GDPFSAEAK-YFHE---AMIG-----NITLGEPPGFLHTWWCVFWDLYCAAPERRDQC-DH--SSEAK-AFHD---YGFV-----NITLGEPPGFLHSWWCVFWDLYCAAPERRETC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRENC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRETC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRETC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRETC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPDRREAC-EH--SGEAK-AFQD---YSAA----
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SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

--NITLGEPPGFLHSWWCVFWDLYCAAPDRREAC-EH--SSEAK-VFQD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPDRREAC-EH--SSEAK-VFQD---YSAA-----NITLGDPPGFLHSWWCVFWDLYCAAPERRDTC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRDTC-DH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRDTC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRDTC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPERRDTC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPDRRETC-EH--SSEAK-AFHD---YSAA-----NITLGEPPGFLHSWWCVFWDLYCAAPDRRETC-EH--SSEAK-AFHD---YSAA---.:
.

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

-AARLQHDAERRGEYSNEDIDPMHLAAMMLGNPMAPAV--QMRNVNMNPI-------PIP
IQKNSLHTGNTSHPYANASFPHDPA----------NAMGQQIDSSQFHQGAGGLNDRNQH
---------------------------------------------------------------MP-------PGMNGHFAPPPMGMEMM-GGHPGAFGGRFAPGRMPPG-------------SS------GYGVNGIGPG---GPHNAGGPAPSP------LGQMPPGGDG-----GP
-----A---------------------------TQSPV-----IGS-PPG-DG-----------A---------------------------APSPV-----LGNMQPG-EG-----------A---------------------------APSPV-----LGNMPPG-DG-----------A---------------------------APSPV-----LGNIPPG-DG-----------A---------------------------APSPV-----LGNMPPG-DG-----------A---------------------------APSPV-----MGSMAPG-DT-----------A---------------------------APSPV-----MGAMTPN-DA----------AA---------------------------APSPV-----MGTLAPN-DA-----------A---------------------------APSPV-----LGNMPPG-DG-----------A---------------------------APSPV-----LGNLPPG-DG-----------A---------------------------APSPV-----LGNIPPN-DG-----------A---------------------------APSPV-----LGNIPPN-DG-----------A---------------------------APSPV-----LGNIPPN-DG-----------A---------------------------APSPV-----MGNMPPN-DG-----------A---------------------------APSPV-----MGNMPPN-DG-------

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

MVGNPIVNNFSIPPYNNANPTTGATAVAPTAPPSGDFTNVGPTQ--------NRS-QNVT
LMRQAMLNNQSRET------------FPPTAAQLQQLKQLHYRQLQSVQQQQKQHQQKKT
-----------------------------------------------------------AMAP--------GG------------MPPGAFPMFPPD---P------------R----MGPG--------GP------------MGPNFFPNSTMRPSPP------------T-HASS
-MP-----------------------LPPGFFQ---------------------------MPV--------GP------------VPPGFFQ---------------------------MPV--------GP------------VPPGFFQ---------------------------MPV--------GP------------VPPGFFQ---------------------------MPV--------GP------------VPPGFFQ---------------------------MAA--------GS------------MAAGFFQGPPGSQPSP------------H-----MAA--------GP------------VAPGFFQ---------------------------MAA--------GP------------VAPGFFQ---------------------------MPG--------GP------------MPPGFFQGPPGSQASP------------H-APPP
-MPG--------GP------------IPPGFFQGPPGSQPSP------------H-AQLP
-MPG--------GP------------IPPGFFQGPPGSQPSP------------H-AQPP
-MPG--------GP------------IPPGFFQGPPGSQPSP------------H-AQPP
-MPG--------GP------------IPPGFFQ---------------------------MPG--------GP------------MPPGFFQGPPGSQPSP------------H-AQPP
-MPG--------GP------------MPPGFFQGPPGSQPSP------------H-AQPP

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM
SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
SSBP2_HUMAN
SSBP2_MOUSE
SSBP4_HUMAN
SSBP4_MOUSE
SSBP4_RAT
SSBP3b_ZEBRAFISH
SSBP3a_ZEBRAFISH
SSBP3_HUMAN
SSBP3_MOUSE
SSBP3_RAT
Zgc:110158_ZEBRAFISH
SSBP4_ZEBRAFISH

GWPVYNYPMQPTTENPVGNPCNNNTTNNTTNNKSPVNQP---KSLKTMHSTDKPNNVPTS
PQSGSTPQMQNTTSQPTT------------HDTHPPKQQGPISDFRSIPSSPK----------------------------------------------------------------------L-QRMA-----------------------------PNQGMR-MPPPPV------G
PQPPPS-QMMPGQPPFMG---------------GPRYPGGPRPGVR-MQGMGNEFNGPPG
---------------QFM---------------SPRYPGGPRGSLR-IPNQAL-G--PGN
---------------PFM---------------SSRYPGGPRPALR-IPNQAL-AGVPGN
---------------PFM---------------SPRYPGGPRPPLR-IPNQAL-GGVPGS
---------------PFM---------------SPRYPGGPRPPLR-IPNQAL-GGVPGS
---------------PFM---------------SPRYPGGPRPPLR-IPNQAL-GGVPGS
--NPNA-PMMGPHGQPFM---------------SPRFPGGPRPTLR-MPSQPP-AGLPGS
---------------PFM---------------SPRFPGGARPILR-MPGQPP-VGLPGS
---------------PFI---------------SPRFPGGARPILR-MPGQPP-VGLPGS
P----N-SMMGPHGQPFM---------------SPRFGGGPRPPIR-MGNQPP-GGVPAA
PN---A-NMMAAHGQPFM---------------SPRYAGGPRPPMR-MGNPPP-G----G
PHNPS--SMMGPHSQPFM---------------SPRYAGGPRPPIR-MGNQPP-GGVPGT
PHNPS--SMMGPHSQPFM---------------SPRYAGGPRPPIR-MGNQPP-GGVPGT
---------------PFM---------------SPRYAGGPRPPIR-MGNQPP-GGVPGT
PHNTSN-PMMGPHGQPFM---------------SPRYPGGPRPSLR-MPNQPP-VGVPGS
PHNPNN-PMMGPHGQPFM---------------SPRYPGGPRPSLR-MPNQPP-VGVPGS

FLO8_BUDDING_YEAST
ADN2_FISSION_YEAST
Y53F4B.5_WORM
SAM-10_WORM

KSTRSRSA--TSKAKGKVKA-GLVAKRRRKNNTATVSAGSTNACSPNITTPGSTTSEPAM
-------------TEGAPSN----AQFRP--SLPATPNGSVPQSNPLYDTTGLNGGQYPV
-----------------------------------------------------------QPFPGAVGMPRPVGPGAPMDMSGMQRFDF-----MGGPPPGGGAQPFPGASGSGGMMPNG
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SSDP_DROSOPHILA
Si:ch211-130m23.3_ZEBRAFISH
SSBP2_ZEBRAFISH
SSBP42_RAT
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